Cargando…
Serum Autoantibody Measurement for the Detection of Hepatocellular Carcinoma
BACKGROUND: Individuals with liver disease, and especially those with Hepatitis B or C, are at an increased risk of developing hepatocellular carcinoma (HCC) which is the third most common cause of cancer-related death worldwide. Inadequate screening tests largely account for presentation of advance...
Autores principales: | Middleton, Catrin H., Irving, William, Robertson, John F. R., Murray, Andrea, Parsy-Kowalska, Celine B., Macdonald, Isabel K., McElveen, Jane, Allen, Jared, Healey, Graham F., Thomson, Brian J., Ryder, Stephen J., Holdenrieder, Stefan, Chapman, Caroline J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122394/ https://www.ncbi.nlm.nih.gov/pubmed/25093332 http://dx.doi.org/10.1371/journal.pone.0103867 |
Ejemplares similares
-
Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma
por: Welberry, Christopher, et al.
Publicado: (2020) -
Application of a High Throughput Method of Biomarker Discovery to Improvement of the EarlyCDT(®)-Lung Test
por: Macdonald, Isabel K., et al.
Publicado: (2012) -
Development and Validation of a High Throughput System for Discovery of Antigens for Autoantibody Detection
por: Macdonald, Isabel K., et al.
Publicado: (2012) -
EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays
por: Chapman, Caroline J., et al.
Publicado: (2012) -
Clinical validation of an autoantibody test for lung cancer
por: Boyle, P., et al.
Publicado: (2011)